Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Mostafa Ronaghi, Joseph Garcia, Jock Finlayson, Brook Byers, More

Premium

Mostafa Ronaghi has joined BaseHealth's board of directors.

Ronaghi currently serves as Illumina's chief technology officer and senior vice president. Before joining Illumina, he founded several life sciences companies including ParAllele BioScience, which was acquired by Affymetrix, as well as Avantome and NextBio, both of which were acquired by Illumina. He also previously spent nine years as a principal investigator at the Stanford Genome Technology Center.


Genome British Columbia has appointed Joseph Garcia and Jock Finlayson to its board of directors.

Garcia is a law partner at Blake, Cassels and Graydon, where he practices in the securities and commercial areas for clients in the life sciences and technology sectors, and he is a member of the board of directors of LifeSciences BC.

Finlayson is executive VP and chief policy officer at the Business Council of British Columbia, where he directs the council's work on economic, fiscal, tax, environmental, regulatory, and human capital issues.


Pacific Biosciences' shareholders have re-elected Brook Byers, John Milligan, and Lucy Shapiro to the company's board of directors.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.